FDA Approves New PARP Inhibitor for Ovarian Cancer
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
Category: Meetings
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
As part of a growing public affairs program, the American Association for Cancer Research is excited to once again...
A big career fair can be somewhat intimidating, so we asked some hiring experts for their advice on how...
In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of...
The AACR has a robust program of educational workshops designed to equip early-career investigators with the knowledge, skills, and...
As social media continues to rapidly grow as a leading source of news and information, it has evolved to...
The AACR Annual Meeting, to be held in Washington, D.C., April 1-5, will showcase the best cancer science and...
Saturday, February 4, is World Cancer Day, an initiative of the Union for International Cancer Control (UICC).
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
Attendees gathered firsthand information on all things breast cancer during the five-day San Antonio Breast Cancer Symposium, which showcased...